📰 Benchmark Research News
Benchmark Research News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Benchmark Research. Real-time updates on events, politics, business and more.
February 7, 2024
Snap’s latest spell as a stock-market darling appears to be ending in major disappointment. Snap stock continued to plummet as Wall Street weighed in on its...
January 31, 2024
SHREVEPORT, La. - Benchmark Research, an Avacare Business is owned by IQVIA, a multinational company serving the combined industries of health information technology and clinical research. Benchmark Research, an Avacare
January 22, 2024
After higher costs and shaky consumer demand caught up with corporate America last year, Wall Street now expects corporate profit margins to rebound through the first half of 2024, as more companies resort to layoffs, technology or other cutbacks in an effort to guard the bottom line and stave off investor anxiety. That rebound wouldAfter higher costs and shaky consumer demand caught up with corporate America last year, Wall Street now expects corporate profit margins to rebound through the firs...
November 10, 2023
"Unity's forward path is clouded with uncertainty," an analyst wrote after the latest earnings report.
September 30, 2023
Across Europe, we are transforming into a continent of content-craving connect-aholics, according to the findings of the AMD European Connectivity Study of over 5,000 online respondents. Sponsored by AMD, in conjunction with independent research company, YouGov, 77% of respondents said they could not live without daily access to the internet.
September 26, 2023
Investors appear skeptical that the transaction will go through along the lines John Malone's investment company has proposed.
May 19, 2023
Curaleaf Holdings Inc. drew a downgrade at Benchmark from buy to hold from Benchmark Research, while Wedbush opted to stick to its outperform rating after the…
April 12, 2023
Columbus, GA (PRWEB) April 04, 2023 -- hyperCORE International has announced the appointment of Carlos E. Orantes, CEO of Alcanza Clinical Research, as
April 4, 2023
Columbus, GA (PRWEB) April 04, 2023 -- hyperCORE International has announced the appointment of Carlos E. Orantes, CEO of Alcanza Clinical Research, as
March 31, 2023
Metas planned 21,000 job cuts will hurt its revenue, leaving it below consensus expectations, Benchmark Research says.